title: Special coverage: 11th retroviruses conference. Novel approaches to HIV vaccine are being studied. One possibility is vaccine that slows disease.
abstract: Dozens of potential HIV vaccine candidates have been studied, and many of the latest additions include novel strategies to elicit HIV antibodies and cytotoxic T-cells, as well as some that may help slow disease progression. Here's a look at some of the talk at the 11th Conference on Retroviruses and Opportunistic Infections.
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology; D018450:Disease Progression; D005822:Genetic Vectors; D015658:HIV Infections / Q000503:physiopathology*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D009500:Neutralization Tests; D016092:Spumavirus / Q000235:genetics
chemical_list: D016915:AIDS Vaccines